starting dose of retatrutide For a 140‑lb adult woman

Most patients qualify for therapy if they have a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related health condition such as type 2 diabetes, high blood pressure, high cholesterol, or sleep apnea

Cost-effectiveness analysis indicates tirzepatide requires a 30% price reduction to meet standard thresholds, while semaglutide needs an 80% price cut from current levels

Ultimately, there is a pressing need to understand whether the beneficial indirect effects of GLP-1RA medications on pancreatic diseases, including PDAC (e.g., weight loss), are negated by direct effects on the pancreas

New England Journal of Medicine , 393 , 2636.

As outlined in our case, postoperative hypoglycemia is difficult to diagnose